148 related articles for article (PubMed ID: 34216690)
1. Intracellular AGR2 transduces PGE2 stimuli to promote epithelial-mesenchymal transition and metastasis of colorectal cancer.
Zhang H; Chi J; Hu J; Ji T; Luo Z; Zhou C; Huang L; Dai Z; Li J; Wang G; Wang L; Wang Z
Cancer Lett; 2021 Oct; 518():180-195. PubMed ID: 34216690
[TBL] [Abstract][Full Text] [Related]
2. AGR2 is controlled by DNMT3a-centered signaling module and mediates tumor resistance to 5-Aza in colorectal cancer.
Li J; Hu J; Luo Z; Zhou C; Huang L; Zhang H; Chi J; Chen Z; Li Q; Deng M; Chen J; Tao K; Wang G; Wang L; Wang Z
Exp Cell Res; 2019 Dec; 385(1):111644. PubMed ID: 31614132
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
4. Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.
Tiemann K; Garri C; Lee SB; Malihi PD; Park M; Alvarez RM; Yap LP; Mallick P; Katz JE; Gross ME; Kani K
Oncogene; 2019 Apr; 38(16):3003-3018. PubMed ID: 30575818
[TBL] [Abstract][Full Text] [Related]
5. DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer.
Liu W; Wang S; Sun Q; Yang Z; Liu M; Tang H
Int J Cancer; 2018 May; 142(10):2068-2079. PubMed ID: 29277893
[TBL] [Abstract][Full Text] [Related]
6. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
7. CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation.
Zhao GX; Xu YY; Weng SQ; Zhang S; Chen Y; Shen XZ; Dong L; Chen S
Oncogene; 2019 Jun; 38(23):4574-4589. PubMed ID: 30742066
[TBL] [Abstract][Full Text] [Related]
8. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
[TBL] [Abstract][Full Text] [Related]
9. PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407.
Tan X; Chen S; Wu J; Lin J; Pan C; Ying X; Pan Z; Qiu L; Liu R; Geng R; Huang W
Cell Death Dis; 2017 Mar; 8(3):e2686. PubMed ID: 28300833
[TBL] [Abstract][Full Text] [Related]
10. uc.338 targets p21 and cyclin D1 via PI3K/AKT pathway activation to promote cell proliferation in colorectal cancer.
Zhang Y; Wang S; Qian W; Ji D; Wang Q; Zhang Z; Wang S; Ji B; Fu Z; Sun Y
Oncol Rep; 2018 Aug; 40(2):1119-1128. PubMed ID: 29901203
[TBL] [Abstract][Full Text] [Related]
11. Lysine-Specific Demethylase 1 Mediates AKT Activity and Promotes Epithelial-to-Mesenchymal Transition in
Miller SA; Policastro RA; Savant SS; Sriramkumar S; Ding N; Lu X; Mohammad HP; Cao S; Kalin JH; Cole PA; Zentner GE; O'Hagan HM
Mol Cancer Res; 2020 Feb; 18(2):264-277. PubMed ID: 31704733
[TBL] [Abstract][Full Text] [Related]
12. Regulation of ATP-binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer.
Wang H; Li JM; Wei W; Yang R; Chen D; Ma XD; Jiang GM; Wang BL
Cancer Sci; 2020 Jan; 111(1):84-97. PubMed ID: 31774615
[TBL] [Abstract][Full Text] [Related]
13. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
14. Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc-xCT.
Tian S; Chu Y; Hu J; Ding X; Liu Z; Fu D; Yuan Y; Deng Y; Wang G; Wang L; Wang Z
Gut; 2022 Dec; 71(12):2489-2501. PubMed ID: 35086885
[TBL] [Abstract][Full Text] [Related]
15. MiR-328-3p inhibits cell proliferation and metastasis in colorectal cancer by targeting Girdin and inhibiting the PI3K/Akt signaling pathway.
Pan S; Ren F; Li L; Liu D; Li Y; Wang A; Li W; Dong Y; Guo W
Exp Cell Res; 2020 May; 390(1):111939. PubMed ID: 32142853
[TBL] [Abstract][Full Text] [Related]
16. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
17. AGR2 is a target of canonical Wnt/β-catenin signaling and is important for stemness maintenance in colorectal cancer stem cells.
Dahal Lamichane B; Jung SY; Yun J; Kang S; Kim DY; Lamichane S; Kim YJ; Park JH; Jang WB; Ji ST; Dehua L; Ha JS; Kim YH; Kwon SM
Biochem Biophys Res Commun; 2019 Aug; 515(4):600-606. PubMed ID: 31178140
[TBL] [Abstract][Full Text] [Related]
18. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
[TBL] [Abstract][Full Text] [Related]
19. TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer.
Yang M; Huang Q; Li C; Jiang Z; Sun J; Wang Z; Liang R; Li D; Li B; Zhao H
Front Immunol; 2021; 12():647540. PubMed ID: 33897695
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of aquaporin 5-mediated epithelial-mesenchymal transition and anti-metastatic effect by natural product Cairicoside E in colorectal cancer.
Chen C; Ma T; Zhang C; Zhang H; Bai L; Kong L; Luo J
Mol Carcinog; 2017 Dec; 56(12):2692-2705. PubMed ID: 28833571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
